Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Roger

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Journal of Neuroimmunology|April 8, 2017
Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedulesMinako Oshima, Philip Deitiker, Tandy Hastings-Ison, et al.
Autoimmunity|September 17, 2010
Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian AmericansPhilip R Deitiker, Minako Oshima, Joseph Jankovic, et al.
Journal of Neuroimmunology|November 15, 2011
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/BMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.
Journal of Neuroimmunology|July 9, 2011
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patientsMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.
The FEBS Journal|May 28, 2014
Fusion of Golgi-derived vesicles mediated by SNAP-25 is essential for sympathetic neuron outgrowth but relatively insensitive to botulinum neurotoxins in vitroGary W Lawrence, Jiafu Wang, Mitchell F Brin, et al.
Analytical Biochemistry|February 9, 2011
Characterization of Förster resonance energy transfer in a botulinum neurotoxin protease assayJustin A Ross, Marcella A Gilmore, Dudley Williams, et al.
Plos One|November 28, 2012
Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassayEster Fernández-Salas, Joanne Wang, Yanira Molina, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2012
Novel chimeras of botulinum and tetanus neurotoxins yield insights into their distinct sites of neuroparalysisJiafu Wang, Tomas H Zurawski, Jianghui Meng, et al.
The Biochemical Journal|February 25, 2012
Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and BJiafu Wang, Tomas H Zurawski, MacDara O Bodeker, et al.
Toxins|June 27, 2015
A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25Catherine Rhéaume, Brian B Cai, Joanne Wang, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Journal of Neuroimmunology|April 8, 2017
Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedulesMinako Oshima, Philip Deitiker, Tandy Hastings-Ison, et al.
Autoimmunity|September 17, 2010
Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian AmericansPhilip R Deitiker, Minako Oshima, Joseph Jankovic, et al.
Journal of Neuroimmunology|November 15, 2011
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/BMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.
Journal of Neuroimmunology|July 9, 2011
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patientsMinako Oshima, Philip R Deitiker, Joseph Jankovic, et al.
The FEBS Journal|May 28, 2014
Fusion of Golgi-derived vesicles mediated by SNAP-25 is essential for sympathetic neuron outgrowth but relatively insensitive to botulinum neurotoxins in vitroGary W Lawrence, Jiafu Wang, Mitchell F Brin, et al.
Analytical Biochemistry|February 9, 2011
Characterization of Förster resonance energy transfer in a botulinum neurotoxin protease assayJustin A Ross, Marcella A Gilmore, Dudley Williams, et al.
Plos One|November 28, 2012
Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassayEster Fernández-Salas, Joanne Wang, Yanira Molina, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2012
Novel chimeras of botulinum and tetanus neurotoxins yield insights into their distinct sites of neuroparalysisJiafu Wang, Tomas H Zurawski, Jianghui Meng, et al.
The Biochemical Journal|February 25, 2012
Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and BJiafu Wang, Tomas H Zurawski, MacDara O Bodeker, et al.
Toxins|June 27, 2015
A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25Catherine Rhéaume, Brian B Cai, Joanne Wang, et al.
Pageof 8